blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3431477

EP3431477 - CONDENSED IMIDAZOLYLIMIDAZOLES AS ANTIVIRAL COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.08.2021
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  11.09.2020
FormerGrant of patent is intended
Status updated on  23.04.2020
FormerExamination is in progress
Status updated on  14.12.2019
FormerRequest for examination was made
Status updated on  21.12.2018
Most recent event   Tooltip15.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 17.08.2022  [2022/33]
Applicant(s)For all designated states
Gilead Pharmasset LLC
333 Lakeside Drive
Foster City, CA 94404 / US
[2019/04]
Inventor(s)01 / BACON, Elizabeth
1218 Floribunda Avenue
Apt. 8
Burlingame, CA 94010 / US
02 / COTTELL, Jeromy
701 Baltic Circle
719
Redwood City, CA 94065 / US
03 / KATANA, Ashley Anne
2201 Bridgepoint Parkway
205
San Mateo, CA 94404 / US
04 / KATO, Darryl
223 Connecticut Street
San Francisco, CA 94107 / US
05 / KRYGOWSKI, Evan
2231 California Street
NW 507
Washington, DC 20008 / US
06 / LINK, John
74 Prospect Avenue
San Francisco, CA 94110 / US
07 / TAYLOR, James
100 State Street
San Mateo, CA 94401 / US
08 / TRAN, Chinh Viet
10322 Baron Drive
San Diego, CA 92126 / US
09 / MARTIN, Teresa Alejandra Trejo
3701 Naughton Ave
Belmont, CA 94002 / US
10 / YANG, Zheng-Yu
338 El Carmelo Avenue
Palo Alto, CA 94306 / US
11 / ZIPFEL, Sheila
22 N. San Mateo Drive
Apt. 205
San Mateo, CA 94401 / US
 [2020/42]
Former [2019/04]01 / BACON, Elizabeth
1218 Floribunda Avenue
Apt. 8
Burlingame, CA 94010 / US
02 / COTTELL, Jeromy
701 Baltic Circle
719
Redwood City, CA 94065 / US
03 / KATANA, Ashley Anne
2201 Bridgepoint Parkway
205
San Mateo, CA 94404 / US
04 / KATO, Darryl
223 Connecticut Street
San Francisco, CA 94107 / US
05 / KRYGOWSKI, Evan
2231 California Street
NW 507
Washington, DC 20008 / US
06 / LINK, John
74 Prospect Avenue
San Francisco, CA 94110 / US
07 / TAYLOR, James
100 State Street
San Mateo, CA 94401 / US
08 / TRAN, Chinh Viet
10322 Baron Drive
San Diego, CA 92126 / US
09 / MARTIN, Teresa Alejandra Trejo
3701 Noughton Ave.
Belmont, CA 94002 / US
10 / YANG, Zheng-Yu
338 El Carmelo Avenue
Palo Alto, CA 94306 / US
11 / ZIPFEL, Sheila
22 N. San Mateo Drive
Apt. 205
San Mateo, CA 94401 / US
Representative(s)Fairbairn, Angus Chisholm
Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[2020/42]
Former [2019/04]Fairbairn, Angus Chisholm
Marks & Clerk LLP
90 Long Acre
London WC2E 9RA / GB
Application number, filing date18175400.316.11.2012
[2019/04]
Priority number, dateUS201161560654P16.11.2011         Original published format: US 201161560654 P
[2019/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3431477
Date:23.01.2019
Language:EN
[2019/04]
Type: B1 Patent specification 
No.:EP3431477
Date:14.10.2020
Language:EN
[2020/42]
Search report(s)(Supplementary) European search report - dispatched on:EP10.10.2018
ClassificationIPC:C07D491/052, A61K31/4188
[2019/04]
CPC:
C07D491/052 (EP,CN,EA,IL,KR,US); A61K31/4188 (EP,EA,IL,KR,US); A61K31/7056 (EP,IL,KR,US);
A61K31/7064 (EP,IL,KR,US); A61K31/7072 (EP,IL,KR,US); A61K38/06 (EP,IL,KR,US);
A61K38/07 (EP,IL,KR,US); A61K38/21 (EP,IL,US); A61K45/06 (EP,IL,KR,US);
A61K47/60 (EP,US); A61P1/16 (EP); A61P31/12 (EP,EA,KR);
A61P31/14 (EP); A61P43/00 (EP); C07D405/12 (EP,US);
C07F5/025 (IL,US); A61K2300/00 (IL,KR) (-)
C-Set:
A61K31/4188, A61K2300/00 (US,EP);
A61K31/7056, A61K2300/00 (EP,US);
A61K31/7064, A61K2300/00 (US,EP);
A61K31/7072, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/04]
Extension statesBA31.05.2018
ME31.05.2018
TitleGerman:KONDENSIERTE IMIDAZOLYLIMIDAZOLE ALS ANTIVIRALE VERBINDUNGEN[2019/04]
English:CONDENSED IMIDAZOLYLIMIDAZOLES AS ANTIVIRAL COMPOUNDS[2019/04]
French:IMIDAZOLYLIMIDAZOLES CONDENSÉS EN TANT QUE COMPOSÉS ANTIVIRAUX[2019/04]
Examination proceduredeletedDate on which the examining division has become responsible
31.05.2018Examination requested  [2019/04]
22.07.2019Amendment by applicant (claims and/or description)
18.12.2019Despatch of a communication from the examining division (Time limit: M04)
30.03.2020Reply to a communication from the examining division
24.04.2020Communication of intention to grant the patent
02.09.2020Fee for grant paid
02.09.2020Fee for publishing/printing paid
02.09.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP12798525.7  / EP2635588
EP15156617.1  / EP2907816
Divisional application(s)EP20194823.9  / EP3778606
Opposition(s)15.07.2021No opposition filed within time limit [2021/38]
Fees paidRenewal fee
31.05.2018Renewal fee patent year 03
31.05.2018Renewal fee patent year 04
31.05.2018Renewal fee patent year 05
31.05.2018Renewal fee patent year 06
27.11.2018Renewal fee patent year 07
27.11.2019Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.11.2012
AL14.10.2020
CY14.10.2020
DK14.10.2020
EE14.10.2020
FI14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
MK14.10.2020
MT14.10.2020
RO14.10.2020
RS14.10.2020
SM14.10.2020
LU16.11.2020
BG14.01.2021
IS14.02.2021
[2022/33]
Former [2022/28]HU16.11.2012
AL14.10.2020
CY14.10.2020
DK14.10.2020
EE14.10.2020
FI14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
MT14.10.2020
RO14.10.2020
RS14.10.2020
SM14.10.2020
LU16.11.2020
BG14.01.2021
IS14.02.2021
Former [2021/45]AL14.10.2020
DK14.10.2020
EE14.10.2020
FI14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
RO14.10.2020
RS14.10.2020
SM14.10.2020
LU16.11.2020
BG14.01.2021
IS14.02.2021
Former [2021/37]DK14.10.2020
EE14.10.2020
FI14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
RO14.10.2020
RS14.10.2020
SM14.10.2020
LU16.11.2020
BG14.01.2021
IS14.02.2021
Former [2021/36]EE14.10.2020
FI14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
RO14.10.2020
RS14.10.2020
SM14.10.2020
LU16.11.2020
BG14.01.2021
IS14.02.2021
Former [2021/35]FI14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
RO14.10.2020
RS14.10.2020
SM14.10.2020
LU16.11.2020
BG14.01.2021
IS14.02.2021
Former [2021/34]FI14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
RS14.10.2020
SM14.10.2020
LU16.11.2020
BG14.01.2021
IS14.02.2021
Former [2021/33]FI14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
RS14.10.2020
SM14.10.2020
LU16.11.2020
BG14.01.2021
IS14.02.2021
Former [2021/32]FI14.10.2020
HR14.10.2020
LV14.10.2020
RS14.10.2020
SM14.10.2020
BG14.01.2021
IS14.02.2021
Former [2021/28]FI14.10.2020
HR14.10.2020
LV14.10.2020
RS14.10.2020
BG14.01.2021
IS14.02.2021
Former [2021/25]FI14.10.2020
LV14.10.2020
RS14.10.2020
BG14.01.2021
IS14.02.2021
Former [2021/24]FI14.10.2020
LV14.10.2020
RS14.10.2020
BG14.01.2021
Former [2021/23]FI14.10.2020
LV14.10.2020
RS14.10.2020
Former [2021/22]FI14.10.2020
RS14.10.2020
Former [2021/20]FI14.10.2020
Documents cited:Search[A]WO2010062821  (GLAXOSMITHKLINE LLC [US], et al) [A] 1-12 * claims 1-37 *;
 [A]WO2010096777  (PRESIDIO PHARMACEUTICALS INC [US], et al) [A] 1-12 * claims 1-55 *;
 [A]WO2011028596  (GLAXOSMITHKLINE LLC [US], et al) [A] 1-12 * claims 1-26 *;
 [A]WO2011066241  (SCHERING CORP [US], et al) [A] 1-12 * claims 1-14 *;
 [A]WO2011087740  (SCHERING CORP [US], et al) [A] 1-12* claims 1-15 *;
 [XP]WO2012068234  (GILEAD SCIENCES INC [US], et al) [XP] 1-12 * claims 1-324 *
by applicantUS4816570
 US4968788
 WO9119721
 WO9615111
 US5663159
 US5792756
 WO2006020276
    - Antimicrobial Agents and Chemotherapy, (20100900), vol. 54, pages 3641 - 3650
    - The Chemistry of Heterocyclic Compounds, A Series of Monographs, John Wiley & Sons, (19500000), vol. 13, 14,
    - J. Am. Chem. Soc., (19600000), vol. 82, page 5566
    - "Design and Application of Prodrugs", BUNDGAARD, HANS, A Textbook of Drug Design and Development, Harwood Academic, (19910000), pages 113 - 191
    - FARQUHAR et al., J. Pharm. Sci., (19830000), vol. 72, page 324
    - DE LOMBAERT et al., J. Med. Chem., (19940000), vol. 37, page 498
    - KHAMNEI; TORRENCE, J. Med. Chem., (19960000), vol. 39, pages 4109 - 4115
    - MITCHELL et al., J. Chem. Soc. Perkin Trans., (19920000), page 112345
    - PUECH et al., Antiviral Res., (19930000), vol. 22, pages 155 - 174
    - BENZARIA et al., J. Med. Chem., (19960000), vol. 39, page 4958
    - Protecting Groups: An Overview, pages 1 - 20
    - Hydroxyl Protecting Groups, pages 21 - 94
    - Diol Protecting Groups, pages 95 - 117
    - Carboxyl Protecting Groups, pages 118 - 154
    - Carbonyl Protecting Groups, pages 155 - 184
    - IAN T. HARRISON; SHUYEN HARRISON, Compendium of Organic Synthetic Methods, John Wiley & Sons, (19710000), vol. 1
    - "Comprehensive Organic Synthesis", Selectivity, Strategy & Efficiency in Modern Organic Chemistry, Pergamon Press, (19930000), vol. 9
    - LOCHMULLER, C. H., J. Chromatogr., (19750000), vol. 113, no. 3, pages 283 - 302
    - ELIEL, E.; WILEN, S., Stereochemistry of Organic Compounds, John Wiley & Sons, Inc., (19940000), page 322
    - JACOB III., J. Org. Chem., (19820000), vol. 47, page 4165
    - OKAMOTO, J. of Chromatogr., (19900000), vol. 513, pages 375 - 378
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.